Literature DB >> 32703006

Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence.

Meydan Turan1, Gulay Turan2.   

Abstract

PURPOSE: Pterygium is a common lesion of the ocular surface, and its etiology and pathogenesis are still uncertain. This study aimed to investigate the role of apoptosis and proliferation in pterygium formation and recurrence.
MATERIALS AND METHODS: In this study, p53, Bcl-2, and Ki-67 expression levels were evaluated in primary pterygium (n = 35) and recurrent pterygium (n = 32) tissue samples and compared with normal conjunctiva (n = 30) tissue samples. In addition, recurrent pterygiums were divided into three groups based on recurrence time, and their p53, Bcl-2, and Ki-67 expression levels were compared.
RESULTS: The results show that p53, Bcl-2, and Ki-67 expression levels were significantly higher in the pterygium tissue samples as compared to the control group (p < 0.001, p < 0.001, and p < 0.001, respectively). When primary and recurrent pterygium tissues were compared, bcl-2 expression was higher in recurrent pterygium tissue samples (p = 0.003). However, when Ki-67 and p53 expression levels were evaluated, no significant difference was found between primary and recurrent pterygium (p = 0.215, p = 0.321, respectively). Also, p53 and Ki-67 expression were correlated in pterygium tissue samples, and Bcl-2 expression was significantly higher in pterygium that recurrence in the first 6 months after surgery. There was no difference between groups 1, 2, and 3 in terms of p53 and Ki-67 expression.
CONCLUSION: Antiapoptotic mechanisms and proliferation play an important role in the etiopathogenesis of pterygium. Furthermore, Bcl-2 expression may be important in pterygium recurrence.

Entities:  

Keywords:  Bcl-2; Ki-67; conjuntiva; immunohistochemistry; p53; pterygium; recurrent pterygium

Mesh:

Substances:

Year:  2020        PMID: 32703006     DOI: 10.1177/1120672120945903

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  3 in total

1.  Commentary: Expression of p53 and Ki-67 proteins in patients with increasing severity and duration of pterygium.

Authors:  Ritu Arora
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

2.  Association among pterygium, cataracts, and cumulative ocular ultraviolet exposure: A cross-sectional study in Han people in China and Taiwan.

Authors:  Natsuko Hatsusaka; Naoki Yamamoto; Hisanori Miyashita; Eri Shibuya; Norihiro Mita; Mai Yamazaki; Teppei Shibata; Hidetoshi Ishida; Yuki Ukai; Eri Kubo; Hong-Ming Cheng; Hiroshi Sasaki
Journal:  PLoS One       Date:  2021-06-15       Impact factor: 3.240

Review 3.  Pterygium-The Good, the Bad, and the Ugly.

Authors:  Sara I Van Acker; Bert Van den Bogerd; Michel Haagdorens; Vasiliki Siozopoulou; Sorcha Ní Dhubhghaill; Isabel Pintelon; Carina Koppen
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.